← Back to all recalls
DRUG RECALLMODERATE
Erythromycin Tablets 250 mg
Zydus recalls Erythromycin 250 mg tablets over impurity above acceptable limit.
What to do
Check your bottle for NDC 70710-1047-3 (30 count) or NDC 70710-1047-1 (100 count). Stop using the affected tablets and return them to the place of purchase for a refund.
Why it was recalled
Zydus Pharmaceuticals is recalling Erythromycin Tablets, USP, 250 mg, due to CGMP deviations and the presence of N-Nitroso-Desmethyl-Erythromycin above the acceptable intake limit.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
| Product | Recall # |
|---|---|
| Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; (NDC 70710-1048-3). | D-0545-2026 |
| Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; a) 30 count bottles (NDC 70710-1047-3); b) 100 count bottles (NDC 70710-1047-1). | D-0544-2026 |
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from Zydus Pharmaceuticals (USA) Inc
Editorial summary by Recall Canary · last updated 2026-07-28 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification